DIGITAL PATHOLOGY SYSTEMS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Digital Pathology Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 47 companies including many key and niche players such as -

3DHISTECH Ltd.
AccelPath, Inc.
Apollo PACS, Inc.
Carl Zeiss MicroImaging GmbH
Corista LLC
Definiens AG


Click here to request a full list of companies covered in the report...

Code : MCP-6740
Price : $4500
Companies : 47
Pages : 321
Date : March 2013
Market Data Tables : 32

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   A Prelude.....II-1
Current & Future Analysis.....II-1
1$100
   Key Trends and Drivers.....II-2
Challenges Ahead for Digital Pathology Systems.....II-2
1$100
   Traditional Pathology Workflow – A Cumbersome Process Laced with Issues.....II-3
The Evolution of Digital Pathology Systems.....II-3
1$100
   Digital Pathology Products and Procedures.....II-4
Digital Pathology as a Service Eludes Cost-based Issues.....II-4
1$100
   Applications of Digital Pathology and the Need for a Management System.....II-5
Digital Pathology in Treatment of Cancer and Other Diseases.....II-5
Digital Pathology in the Clinical Research Scenario.....II-5
1$100
   Telepathology Expected to Pave Way for Pathology Outsourcing to Developing
  Nations.....II-6
Cloud Hosting and Web-based Applications Offer Cost-Effective Digital Pathology
  Options.....II-6
A Review of Information Archival and Retrieval in Digital Pathology.....II-6
1$100
   Storage and Interoperability.....II-7
Location and Internal Communication.....II-7
Systems and Data Reliability.....II-7
1$100
   Image Life-Cycle Management.....II-8
IT infrastructure and Management Costs.....II-8
Factors Affecting Information Archival.....II-8
1$100
   Leading Players.....II-9
Table 1: Leading Players in the Global Digital Pathology Systems Market (2012): Percentage Breakdown of Dollar Sales for Leica/Aperio, Ventana, Olympus and Others (includes corresponding Graph/Chart).....II-9
Consolidation Rife in the Digital Pathology Space.....II-9
1$350
   Leica’s Acquisition of Aperio – The Underlying Rationale.....II-101$100
   An Introduction to Pathology.....II-11
What is Digital Pathology?.....II-11
Benefits of Digital Pathology.....II-11
1$100
   Access to Digital Slide Images Anytime Anywhere.....II-12
Digital Pathology Management Systems.....II-12
Easier Analysis and Retrieval of Digital Images.....II-12
1$100
   Applications.....II-13
Remote Reviewing.....II-13
Digital-Assisted Mathematical Analysis.....II-13
Data Storage.....II-13
Telepathology.....II-13
1$100
   Static Telepathology.....II-14
Dynamic Telepathology.....II-14
Hybrid Telepathology.....II-14
Bio-banking.....II-14
Multinational Integration.....II-14
1$100
   Tissue Microarray Analysis.....II-151$100
   Ventana Medical Systems Launches iScan HT Slide Scanner.....II-16
Aperio Technologies Introduces Release 11.0 of Digital Pathology System.....II-16
Omnyx Showcases Upcoming Integrated Digital Pathology Solution.....II-16
1$100
   Pixcelldata Unveils Collibio Desktop Version.....II-17
Carl Zeiss MicroImaging Launches LSM 700 Microscope.....II-17
Agfa Healthcare Unveils Integrated Digital Pathology Solution.....II-17
1$100
   Leica Microsystems Expands Capabilities of Leica SCN400 and SCN400 F Scanners.....II-18
Omnyx Unveils Omnyx™ VL4 Scanner to Beta Consumers.....II-18
1$100
   Leica Microsystems Launches Total Digital Pathology Solution.....II-19
Definiens® Unveils Quantitative Digital Pathology Portfolio.....II-19
1$100
   Aperio Technologies Introduces ScanScope AT Pathology Slide Scanner.....II-20
MikroScan Technologies Unveils MikroScan D2 Slide Imaging Scanner.....II-20
1$100
   Caliper® Life Sciences Introduces Vectra™ 2 with AQUA Technology for Quantification
  of Protein Biomarkers.....II-21
Philips to Introduce Digital Pathology Technology.....II-21
BioImagene Launches Digital Pathology Solutions in Europe.....II-21
BioImagene Unveils Next Generation Virtuoso™ and iScan Coreo Au Slide Scanner.....II-21
1$100
   Definiens Develops Novel Software Application.....II-22
MikroScan Technologies Unveils New Product Range.....II-22
1$100
   Aperio Technologies Unveils Discover Your Path Assessment Program for
  Hospitals.....II-23
CBLPath Introduces Best Practice™ Partnership Program.....II-23
Nikon Instruments Launches Mi Macro Imaging Grossing Station.....II-23
1$100
   Definiens Introduces Definiens Tissue Studio.....II-24
BioImagene Introduces Crescendo DPW.....II-24
Aperio Technologies Introduces Clinical Partner Service Program.....II-24
1$100
   Targeted Molecular Diagnostics Introduces Digital Pathology Services in China.....II-25
Applied Spectral Imaging Launches PathEx Duo Detection System.....II-25
Aperio Technologies Launches Digital IHC Solution.....II-25
1$100
   Visuvi and BioImagene Launch PathSearch™.....II-26
Amirsys Integrates PathIQ ImmunoQuery with Virtuoso of BioImagene.....II-26
1$100
   Leica Biosystems Takes Over Aperio Technologies.....II-27
Carl Zeiss MicroImaging and Olympus America Sign Licensing Agreement.....II-27
1$100
   Aperio Technologies and Dell Enter into Strategic Collaboration.....II-28
Erasmus MC Selects Philips to Adopt Digital Pathology System.....II-28
Leica Microsystems and Indica Labs Sign Agreement.....II-28
Ventana Medical Systems Obtains USFDA 510(k) Clearance for VENTANA Companion Algorithm
  Ki-67 (30-9) Image Analysis Solution.....II-28
1$100
   AccelPath Acquires DigiPath Solutions.....II-29
Omnyx™ Receives CE Mark in Europe.....II-29
XStor Systems and Quorum Technologies Enter Into Distribution Partnership.....II-29
1$100
   Royal Philips Electronics and NEC Ink Agreement.....II-30
GE Healthcare Enters into Partnership with Singapore General Hospital.....II-30
1$100
   PathXL Enters into Partnership with Visiopharm.....II-31
Aperio Technologies Enters into Partnership with Definiens to Market Definiens Tissue
  Studio™.....II-31
1$100
   Caliper Life Sciences Takes Over CRi.....II-32
Ventana Medical Systems Takes Over BioImagene.....II-32
Leica Microsystems Acquires Genetix.....II-32
1$100
   Dartmouth-Hitchcock Medical Center to Deploy BioImagene Solutions.....II-33
Royal Philips Electronics Ink Cooperation Agreement with Definiens.....II-33
UPMC and GE Healthcare Enter into Joint Venture.....II-33
1$100
   i-Path Diagnostics and iSOFT Group to Enter into Partnership.....II-34
KUMC and BioImagene Enter into Collaboration.....II-34
CRi and 3DHISTECH Ink Exclusive Agreements.....II-34
1$100
   BioImagene and LigoLab Develop New Interface.....II-35
Olympus America and Omnyx Ink Nonexclusive Global Licensing Agreement.....II-35
Aperio Technologies and ADCIS Enter into Partnership.....II-35
1$100
   VMscope and Pixcelldata Enter into Partnership.....II-36
Aperio Technologies Receives Patent from United States Patent and Trademark
  Office.....II-36
Royal Philips Electronics and Dako Ink Agreement.....II-36
1$100
   Dako Signs Agreement with Omnyx.....II-37
Flagship Biosciences Inks Service Partnership with Expression Pathology.....II-37
1$100
   Flagship Biosciences Establishes Digital Pathology office in Boston Suburbs.....II-38
Omnyx to Commence Clinical Research Testing of Omnyx Integrated Digital Pathology
  Solution.....II-38
Henry Ford Health System to Deploy PathPACS® of Apollo PACS.....II-38
1$100
   Genetix Takes Over SlidePath.....II-39
Omnyx Receives Patent from US Patent and Trademark Office.....II-39
1$100
   3DHISTECH Ltd. (Hungary).....II-40
AccelPath, Inc. (US).....II-40
1$100
   Apollo PACS, Inc. (US).....II-41
Carl Zeiss MicroImaging GmbH (Germany).....II-41
1$100
   Corista LLC (US).....II-42
Definiens AG (Germany).....II-42
DigiPath Inc. (US).....II-42
1$100
   Flagship Biosciences, LLC (US).....II-43
Koninklijke Philips Electronics N.V. (Netherlands).....II-43
1$100
   Leica Microsystems GmbH (Germany).....II-44
Aperio Technologies, Inc. (US).....II-44
1$100
   MikroScan Technologies, Inc. (US).....II-45
Olympus America, Inc. (US).....II-45
1$100
   Omnyx, LLC (US).....II-46
Pixcelldata Ltd. (Ireland).....II-46
Ventana Medical Systems, Inc. (US).....II-46
1$100
   BioImagene, Inc. (US).....II-47
VMscope GmbH (Germany).....II-47
1$100
   Table 2: World Recent Past, Current and Future Analysis for Digital Pathology Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-481$350
   Table 3: World Historic Review for Digital Pathology Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-491$350
   Table 4: World 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2004, 2012, and 2018 (includes corresponding Graph/Chart).....II-501$350
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Regulatory Scenario in the US.....III-1
Health Insurance Portability and Accountability Act (HIPAA).....III-1
Food and Drug Administration (FDA).....III-1
Clinical Laboratory Improvement Amendments (CLIA).....III-1
1$75
   Product Launches.....III-26$450
   Strategic Corporate Developments.....III-88$600
   Key Players.....III-166$450
   B. Market Analytics.....III-22
Table 5: US Recent Past, Current and Future Analysis for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-22
1$200
   Table 6: US Historic Review for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-231$200
   A. Market Analysis.....III-24
Current & Future Analysis.....III-24
Need for Digital Pathology in Canada.....III-24
Strategic Corporate Development.....III-24
1$75
   B. Market Analytics.....III-25
Table 7: Canadian Recent Past, Current and Future Analysis for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-25
1$200
   Table 8: Canadian Historic Review for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-261$200
   Market Analysis.....III-27
Table 9: Japanese Recent Past, Current and Future Analysis for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-27
1$200
   Table 10: Japanese Historic Review for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-281$200
   A. Market Analysis.....III-29
Current & Future Analysis.....III-29
Product Launches.....III-29
4$300
   Strategic Corporate Developments.....III-334$300
   Key Players.....III-374$300
   B. Market Analytics.....III-41
Table 11: European Recent Past, Current and Future Analysis for Digital Pathology Systems by Country/Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-41
1$200
   Table 12: European Historic Review for Digital Pathology Systems by Country/Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-421$200
   Table 13: European 15-Year Perspective for Digital Pathology Systems by Country/Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2004, 2012, and 2018 (includes corresponding Graph/Chart).....III-431$200
   A. Market Analysis.....III-44
Current & Future Analysis.....III-44
Product Launch.....III-44
Strategic Corporate Development.....III-44
1$75
   B. Market Analytics.....III-45
Table 14: Asia-Pacific Recent Past, Current and Future Analysis for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-45
1$200
   Table 15: Asia-Pacific Historic Review for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-461$200
   A. Market Analysis.....III-47
Current & Future Analysis.....III-47
Product Launch.....III-47
1$75
   B. Market Analytics.....III-48
Table 16: Rest of World Recent Past, Current and Future Analysis for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-48
1$200
   Table 17: Rest of World Historic Review for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-491$200
  
Total Companies Profiled: 46 (including Divisions/Subsidiaries - 51)

Region/Country Players

The United States 30 Canada 3 Japan 2 Europe 15 Germany 6 The United Kingdom 1 Spain 1 Rest of Europe 7 Asia-Pacific (Excluding Japan) 1
Click here to request a full table of contents and more details on this project.